Alcyone MEMS Cannula

The US Food and Drug Administration (FDA) has granted clearance for Alcyone Lifesciences’ Alcyone MEMS Cannula (AMC), a neuro-ventricular cannula.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The AMC is a dual-lumen, MRI-compatible injection and aspiration cannula, designed for use in the brain.

The company said the AMC is not intended for implant and was developed for single patient use only.

"The AMC is a dual-lumen, MRI-compatible injection and aspiration cannula, designed for use in the brain."

Alcyone Lifesciences founder PJ Anand said: "The neuroscience community is pioneering new therapeutic agents including gene therapy, antibody and oncolytic biologic therapy that hold great promise in treating chronic CNS disorders, but unfortunately they have lacked a clinically effective technology for precise CNS delivery direct to a neurological target and for optimal bio-distribution.

"Given that the very potential of these new agents is dependent on optimal bio-distribution, it is our hope that the AMC will offer a solution for this critical unmet clinical need and further open the gates to novel therapeutic options for patients."

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Developed using the company’s microelectromechanical system (MEMS) platform, the AMC can be used with any existing commercial imaging and stereotactic system.

Alcyone director of Product Development Deep Singh said: "Neurosurgeons can select a target, navigate the AMC precisely to the target, and observe in real-time the precision delivery of the therapeutic agent, all under intra-procedural MRI guidance."

Apart from the MEMS tip which has dual micro-channels, the AMC features a patented distal end design that helps prevent reflux or back flow along the cannula shaft, which can be a significant drawback with current devices.

Image: Alcyone MEMS Cannula. Photo: courtesy of Business Wire / Alcyone Lifesciences Inc.

Medical Device Network Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Medical Device Network Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving medical devices advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now